- -11%
- New
(edit with the Customer Reassurance module)
(edit with the Customer Reassurance module)
(edit with the Customer Reassurance module)
The Deca/NPP Blend is Dragon Pharma's formulation of two Nandrolone esters in a single 350mg/ml vial β Nandrolone Decanoate at 200mg/ml and Nandrolone Phenylpropionate at 150mg/ml. Unlike blends that combine different active compounds, this product combines two esters of the same molecule to engineer a specific release profile: NPP's faster onset layered beneath Deca's prolonged sustained release.
Also searched as: Deca NPP blend, Nandrolone dual ester, Deca 200 NPP 150 Dragon Pharma, Nandrolone blend 350mg.
This blend is unique in the Dragon Pharma range β two esters of identical active compound combined to produce a release profile neither ester achieves alone. This is the Nandrolone equivalent of the multi-ester testosterone logic in Sustanon:
| Component | Amount | Half-Life | Role in Blend |
|---|---|---|---|
| Nandrolone Phenylpropionate (NPP) | 150 mg/ml | ~5 days | Faster onset β blood levels build within the first week; earlier joint comfort and anabolic effects |
| Nandrolone Decanoate (Deca) | 200 mg/ml | ~15 days | Sustained baseline β maintains elevated Nandrolone levels throughout the full cycle with less frequent contribution from the short ester |
The combined result: within the first 1-2 weeks, the NPP component produces a meaningful Nandrolone blood level while the Deca component is still building. By weeks 4-6, the Deca component has reached steady-state and becomes the dominant contributor. The blend therefore avoids the primary criticism of standalone Deca β that a 14-16 week cycle is required before full steady-state is achieved β while retaining Deca's sustained, stable long-term levels.
| Protocol | Meaningful blood levels by week... | Steady-state by week... | PCT start post-cycle |
|---|---|---|---|
| Standalone Deca only (~15 day tΒ½) | Week 3β4 | Week 10β12 | 3β4 weeks post |
| Standalone NPP only (~5 day tΒ½) | Week 1β2 | Week 3β4 | 10β14 days post |
| Deca/NPP Blend (this product) | Week 1β2 (NPP component) | Week 8β10 (Deca component) | 3β4 weeks post (Deca-governed) |
Important: PCT timing is governed by the longest ester present β the Deca component's ~15-day half-life means PCT cannot begin until 3-4 weeks after the last injection, the same as standalone Deca. The NPP component clears sooner, but the Deca component's ongoing suppression means waiting for it to clear before PCT can be effective.
| Experience Level | Weekly Dose | Frequency | Cycle Length |
|---|---|---|---|
| Intermediate | 350β525 mg/week (1β1.5ml) | Twice weekly | 12β16 weeks |
| Advanced | 525β700 mg/week (1.5β2ml) | Twice weekly | 12β16 weeks |
Twice-weekly injection provides stable combined blood levels β the NPP component's ~5-day half-life benefits from twice-weekly dosing, while the Deca component is stable on once or twice weekly. Splitting the weekly dose into two injections maintains tighter levels from both components simultaneously. At 350mg/ml, a 1ml twice-weekly injection delivers 700mg/week total Nandrolone (400mg Deca + 300mg NPP).